Literature DB >> 15755687

Role of mitochondria in neuronal cell death induced by oxidative stress; neuroprotection by Coenzyme Q10.

M Somayajulu1, S McCarthy, M Hung, M Sikorska, H Borowy-Borowski, S Pandey.   

Abstract

Neuronal cells depend on mitochondrial oxidative phosphorylation for most of their energy needs and therefore are at a particular risk for oxidative stress. Mitochondria play an important role in energy production and oxidative stress-induced apoptosis. In the present study, we have demonstrated that external oxidative stress induces mitochondrial dysfunction leading to increased ROS generation and ultimately apoptotic cell death in neuronal cells. Furthermore, we have investigated the role of Coenzyme Q10 as a neuroprotective agent. Coenzyme Q10 is a component of the mitochondrial respiratory chain and a potent anti-oxidant. Our results indicate that total cellular ROS generation was inhibited by Coenzyme Q10. Further, pre-treatment with Coenzyme Q10 maintained mitochondrial membrane potential during oxidative stress and reduced the amount of mitochondrial ROS generation. Our study suggests that water-soluble Coenzyme Q10 acts by stabilizing the mitochondrial membrane when neuronal cells are subjected to oxidative stress. Therefore, Coenzyme Q10 has the potential to be used as a therapeutic intervention for neurodegenerative diseases.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15755687     DOI: 10.1016/j.nbd.2004.10.021

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  52 in total

1.  Design and evaluation of multifunctional nanocarriers for selective delivery of coenzyme Q10 to mitochondria.

Authors:  Anjali Sharma; Ghareb M Soliman; Noura Al-Hajaj; Rishi Sharma; Dusica Maysinger; Ashok Kakkar
Journal:  Biomacromolecules       Date:  2011-12-16       Impact factor: 6.988

2.  Dietary fats, cholesterol and iron as risk factors for Parkinson's disease.

Authors:  Karen M Powers; Terri Smith-Weller; Gary M Franklin; W T Longstreth; Phillip D Swanson; Harvey Checkoway
Journal:  Parkinsonism Relat Disord       Date:  2008-04-18       Impact factor: 4.891

Review 3.  Role of HMG-CoA reductase inhibitors in neurological disorders : progress to date.

Authors:  Allison B Reiss; Elzbieta Wirkowski
Journal:  Drugs       Date:  2007       Impact factor: 9.546

Review 4.  Redox Signaling Mediated by Thioredoxin and Glutathione Systems in the Central Nervous System.

Authors:  Xiaoyuan Ren; Lili Zou; Xu Zhang; Vasco Branco; Jun Wang; Cristina Carvalho; Arne Holmgren; Jun Lu
Journal:  Antioxid Redox Signal       Date:  2017-05-18       Impact factor: 8.401

Review 5.  Mitochondrial approaches for neuroprotection.

Authors:  Rajnish K Chaturvedi; M Flint Beal
Journal:  Ann N Y Acad Sci       Date:  2008-12       Impact factor: 5.691

6.  Nanomicellar formulation of coenzyme Q10 (Ubisol-Q10) effectively blocks ongoing neurodegeneration in the mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model: potential use as an adjuvant treatment in Parkinson's disease.

Authors:  Marianna Sikorska; Patricia Lanthier; Harvey Miller; Melissa Beyers; Caroline Sodja; Bogdan Zurakowski; Sandhya Gangaraju; Siyaram Pandey; Jagdeep K Sandhu
Journal:  Neurobiol Aging       Date:  2014-04-02       Impact factor: 4.673

7.  Paraquat induces oxidative stress, neuronal loss in substantia nigra region and parkinsonism in adult rats: neuroprotection and amelioration of symptoms by water-soluble formulation of coenzyme Q10.

Authors:  Mallika Somayajulu-Niţu; Jagdeep K Sandhu; Jerome Cohen; Marianna Sikorska; T S Sridhar; Anca Matei; Henryk Borowy-Borowski; Siyaram Pandey
Journal:  BMC Neurosci       Date:  2009-07-27       Impact factor: 3.288

8.  Coenzyme Q10 effects in neurodegenerative disease.

Authors:  Meredith Spindler; M Flint Beal; Claire Henchcliffe
Journal:  Neuropsychiatr Dis Treat       Date:  2009-11-16       Impact factor: 2.570

9.  Coenzyme Q10 protect against ischemia/reperfusion induced biochemical and functional changes in rabbit urinary bladder.

Authors:  Yung-Shun Juan; Tasmina Hydery; Anita Mannikarottu; Barry Kogan; Catherine Schuler; Robert E Leggett; Wei-Yu Lin; Chun-Hsiung Huang; Robert M Levin
Journal:  Mol Cell Biochem       Date:  2007-12-30       Impact factor: 3.396

10.  Targeting the progression of Parkinson's disease.

Authors:  J L George; S Mok; D Moses; S Wilkins; A I Bush; R A Cherny; D I Finkelstein
Journal:  Curr Neuropharmacol       Date:  2009-03       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.